新規登録 | ログイン | FAQ      [?] 

タグ: hplp [20 articles]

Recent papers classified by the tag hplp.
  • Metabolic effects of a growth hormone-releasing factor in patients with HIV.
    N Engl J Med, Vol. 357, No. 23. (6 December 2007), pp. 2359-2370.
    by J Falutz, S Allas, K Blot, D Potvin, D Kotler, M Somero, D Berger, S Brown, G Richmond, J Fessel, R Turner, S Grinspoon
    posted to hplp lipodystrophy metabolic-syndrome therapy by omalbam on 2008-01-09 03:57:45 as **
  • notes Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake
    Am J Clin Nutr, Vol. 85, No. 3. (1 March 2007), pp. 678-687.
    by Janne K Lorenzen, Sanne Nielsen, Jens J Holst, Inge Tetens, Jens F Rehfeld, Arne Astrup
    posted to calcium diet hplp physiology by omalbam on 2008-01-23 14:11:50 as **
  • Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
    N Engl J Med (30 March 2008), NEJMoa0800742.
    by John J Kastelein, Fatima Akdim, Erik S Stroes, Aeilko H Zwinderman, Michiel L Bots, Anton F Stalenhoef, Frank L Visseren, Eric J Sijbrands, Mieke D Trip, Evan A Stein, Daniel Gaudet, Raphael Duivenvoorden, Enrico P Veltri, David A Marais, Eric de Groot, The E Investigators
    posted to hplp rct risk vasculardisease by omalbam on 2008-04-07 15:49:31 as ** along with 3 people A_Hoogendam rdragu jyuh
  • notes Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.
    Am Heart J, Vol. 153, No. 2. (February 2007)
    posted to hplp therapy by omalbam on 2008-01-08 18:57:37 as ** along with 1 person dougherb
  • notes Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
    JAMA, Vol. 298, No. 3. (18 July 2007), pp. 299-308.
    posted to chd hplp metabolic-syndrome by omalbam on 2008-01-08 17:10:16 as ** along with 1 person jyuh
  • The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction.
    Clin Chem, Vol. 51, No. 7. (July 2005), pp. 1110-1115.
    posted to androgen diagnosis hplp molecular by omalbam on 2008-01-29 20:05:54 as **
  • notes Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk
    Am J Physiol Endocrinol Metab, Vol. 284, No. 6. (1 June 2003), pp. E1112-1118.
    by Karen L Herbst, John K Amory, John D Brunzell, Howard A Chansky, William J Bremner
    posted to aging hplp physiology rct testosterone by omalbam on 2008-02-02 15:12:58 as **
  • Relation of plasma lipids to all-cause mortality in Caucasian, African-American and Hispanic elders.
    Age and ageing, Vol. 37, No. 2. (March 2008), pp. 207-213.
    by JL Akerblom, R Costa, JA Luchsinger, JJ Manly, MX Tang, JH Lee, R Mayeux, N Schupf
    posted to ethnic hplp mortality risk by omalbam on 2008-04-04 20:28:33 as **
  • Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male
    Eur J Endocrinol, Vol. 151, No. 4. (1 October 2004), pp. 415-424.
    by F Schleich, JJ Legros
    posted to aging androgen hplp malegonadal review therapy by omalbam on 2008-01-30 19:14:00 as **
  • notes Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    The American journal of cardiology, Vol. 101, No. 3. (1 February 2008), pp. 279-285.
    posted to cardiovascular hplp nephropathy prevention by omalbam on 2008-04-15 21:34:40 as **
  • HIV and HIV treatment: effects on fats, glucose and lipids
    Br Med Bull, Vol. 84, No. 1. (1 January 2007), pp. 49-68.
    by Effrossyni Gkrania-Klotsas, Angelos-Emmanouil Klotsas
    posted to hplp lipodystrophy therapy by omalbam on 2008-01-09 17:17:14 as **
  • notes Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Clin Ther, Vol. 29, No. 7. (July 2007), pp. 1354-1367.
    by MH Davidson, EA Stein, HE Bays, KC Maki, RT Doyle, RA Shalwitz, CM Ballantyne, HN Ginsberg,
    posted to chd hplp prevention w3 by omalbam on 2008-01-07 20:52:55 as **
  • notes Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Arterioscler Thromb Vasc Biol, Vol. 27, No. 6. (June 2007), pp. 1417-1425.
    by CQ Lai, DK Arnett, D Corella, RJ Straka, MY Tsai, JM Peacock, X Adiconis, LD Parnell, JE Hixson, MA Province, JM Ordovas
    posted to hplp therapy by omalbam on 2008-01-08 18:42:48 as **
  • notes Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis.
    J Am Coll Cardiol, Vol. 49, No. 20. (22 May 2007), pp. 2003-2009.
    by S Kinlay
    posted to crp hplp therapy by omalbam on 2008-01-08 18:49:58 as **
  • Androgens and Coronary Artery Disease
    Endocr Rev, Vol. 24, No. 2. (1 April 2003), pp. 183-217.
    by Fredrick C Wu, Arnold von Eckardstein
    posted to androgen chd hplp review by omalbam on 2008-02-02 15:26:01 as ** along with 1 person FW_Gibb
  • notes Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Clin Ther, Vol. 29, No. 1. (January 2007), pp. 74-83.
    by FJ Zieve, MF Kalin, SL Schwartz, MR Jones, WL Bailey
    posted to diabetes hplp rct by omalbam on 2008-03-11 16:14:54 as **
  • notes Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
    N Engl J Med, Vol. 358, No. 12. (20 March 2008), pp. 1240-1249.
    by Sekar Kathiresan, Olle Melander, Dragi Anevski, Candace Guiducci, Noel P Burtt, Charlotta Roos, Joel N Hirschhorn, Goran Berglund, Bo Hedblad, Leif Groop, David M Altshuler, Christopher Newton-Cheh, Marju Orho-Melander
    posted to genetic hplp molecular risk by omalbam on 2008-04-15 21:24:41 as ** along with 2 people kochhan jyuh
  • Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
    BMJ, Vol. 336, No. 7645. (22 March 2008), pp. 645-651.
    by Giovanni F Strippoli, Sankar D Navaneethan, David W Johnson, Vlado Perkovic, Fabio Pellegrini, Antonio Nicolucci, Jonathan C Craig
    posted to hplp meta-analysis renal review therapy by omalbam on 2008-03-24 20:34:06 as ** along with 1 person jyuh
  • Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease
    QJM, Vol. 101, No. 2. (1 February 2008), pp. 111-119.
    by LM Ntyintyane, VR Panz, FJ Raal, GV Gill
    posted to chd hplp metabolic-syndrome by omalbam on 2008-02-07 14:52:27 as **
  • Effects of torcetrapib in patients at high risk for coronary events.
    N Engl J Med, Vol. 357, No. 21. (22 November 2007), pp. 2109-2122.
    by PJ Barter, M Caulfield, M Eriksson, SM Grundy, JJ Kastelein, M Komajda, J Lopez-Sendon, L Mosca, JC Tardif, DD Waters, CL Shear, JH Revkin, KA Buhr, MR Fisher, AR Tall, B Brewer,
    posted to chd hplp sideffects therapy by omalbam on 2008-01-09 04:08:33 as **
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/tag/hplp

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.